Genetic Mutation Test Kit

Sample Type Blood, Plasma
Applications For Genetic Mutations, For Breast Cancer
Tested Parameter Genetic
SKU: db473cbee5a3 Category: Tags: , ,
Description

Extremely sensitive to mutant allele fractions as low as 0.06%.Quantitative detection of six mutant molecules or more with a 95% confidence levelinput:
output:Two-day turnaround timeinput:
output:IVD-certified software facilitates data analysis and reporting.Plasma-SeqSensei™ (PSS) assays utilize next-generation sequencing technology to facilitate the highly sensitive and quantitative detection of mutations in circulating tumor DNA (ctDNA) from the blood plasma of breast cancer patients. The results of PSS’s short and standardized workflow are delivered within two days, and the generation of reports that are easily readable on laptops is facilitated by Plasma-SeqSensei™ IVD Software.input:
output:The kit is designed to identify established and emerging predictive markers, resistance mutations, and frequently occurring genetic alterations in breast cancer by analyzing key gene mutations, including AKT1, ERBB2, ESR1, KRAS, PIK3CA, and TP53.The PSS Breast Cancer IVD Kit is designed to provide clinicians with the necessary support regarding:input:
output:identifying the presence of minimal residual diseasesurveillance that occurs repeatedly(neo-)adjuvant response monitoringinput:
output:PSS technologyMutant reporting with confidenceSafeSEQ technology is implemented in the PSS library preparation workflow to enhance sensitivity and minimize error rates associated with sequencing. During the target selection phase, this technology assigns a unique identifier (UID) to each DNA molecule. UIDs assist in the identification and tracking of genuine mutations in samples, as well as the differentiation of these mutations from errors or polymerase or sequencing errors. In a background of 10,000 wild-type copies, PSS can detect mutant allele fractions (MAF) of 0.06% and higher with 95% certainty.

 

 

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.